Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Placencio, Veronica R ^a   Li, Xiaohong ^a,b   Sherrill, Taylor P ^b   Fritz, Gloria ^b   Bhowmick, Neil A ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BETA GALACTOSIDASE; CHEMOKINE; CYTOKERATIN 8; GREEN FLUORESCENT PROTEIN; PROTEIN P63; SECRETED FRIZZLED RELATED PROTEIN 2; TESTOSTERONE; WNT PROTEIN; GT(ROSA)26SOR PROTEIN, MOUSE; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER RESISTANCE; CELL POPULATION; CONTROLLED STUDY; EPITHELIUM CELL; FETUS; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PROSTATE; PROSTATE TUMOR; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS;

ANIMALS; BONE MARROW CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROSTATE; PROSTATIC NEOPLASMS; PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77958605766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012920     Document Type: Article

References (46)

1. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, et al. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461: 495-500.
2. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, et al. (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157: 1257-1265.
3. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, et al. (2004) TGFbeta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851.
4. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350.
5. Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, et al. (2008) Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res 68: 4709-4718.
6. Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, et al. (2008) Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene.
7. Yu X, Wang Y, Jiang M, Bierie B, Roy-Burman P, et al. (2009) Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration. Prostate 69: 249-262.
8. Bisson I, Prowse DM (2009) WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 19: 683-697.
9. Houghton J, Morozov A, Smirnova I, Wang TC (2007) Stem cells and cancer. Semin Cancer Biol 17: 191-203.
10. Liu C, Chen Z, Chen Z, Zhang T, Lu Y (2006) Multiple tumor types may originate from bone marrow-derived cells. Neoplasia 8: 716-724.
11. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M (2010) B-cellderived lymphotoxin promotes castration-resistant prostate cancer. Nature 464: 302-305.
12. Vassilopoulos G, Wang PR, Russell DW (2003) Transplanted bone marrow regenerates liver by cell fusion. Nature 422: 901-904.
13. Davies PS, Powell AE, Swain JR, Wong MH (2009) Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One 4: e6530.
14. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, et al. (2004) Gastric cancer originating from bone marrow-derived cells. Science 306: 1568-1571.
15. Ichim TE, Alexandrescu DT, Solano F, Lara F, Campion Rde N, et al. (2010) Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol 260: 75-82.
16. Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319.
17. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
18. Fritz V, Noel D, Bouquet C, Opolon P, Voide R, et al. (2008) Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor. Stem Cells 26: 2981-2990.
19. Fritz V, Jorgensen C (2008) Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Curr Stem Cell Res Ther 3: 32-42.
20. Reinders ME, Fibbe WE, Rabelink TJ (2010) Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 25: 17-24.
21. Song H, Song BW, Cha MJ, Choi IG, Hwang KC (2010) Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther 10: 309-319.
22. Alison MR, Lim S, Houghton JM (2009) Bone marrow-derived cells and epithelial tumours: more than just an inflammatory relationship. Curr Opin Oncol 21: 77-82.
23. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, et al. (2007) Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694.
24. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, et al. (2003) Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422: 897-901.
25. Phinney DG, Kopen G, Isaacson RL, Prockop DJ (1999) Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72: 570-585.
26. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, et al. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284.
27. Dan YY, Yeoh GC (2008) Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 23: 687-698.
28. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-2581.
29. Terry S, Yang X, Chen MW, Vacherot F, Buttyan R (2006) Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. J Cell Biochem 99: 402-410.
30. Verras M, Sun Z (2006) Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 237: 22-32.
31. Vaday GG, Peehl DM, Kadam PA, Lawrence DM (2006) Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66: 124-134.
32. Xu WT, Bian ZY, Fan QM, Li G, Tang TT (2009) Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 281: 32-41.
33. Boomershine CS, Chamberlain A, Kendall P, Afshar-Sharif AR, Huang H, et al. (2009) Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut 58: 1267-1274.
34. Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, et al. (2006) Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci U S A 103: 6321-6325.
35. Palapattu GS, Meeker A, Harris T, Collector MI, Sharkis SJ, et al. (2006) Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium. J Urol 176: 813-818.
36. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377.
37. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, et al. (2004) Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104: 3581-3587.
38. Li HC, Stoicov C, Rogers AB, Houghton J (2006) Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 12: 363-371.
39. Dittmar T, Nagler C, Schwitalla S, Reith G, Niggemann B, et al. (2009) Recurrence cancer stem cells-made by cell fusion? Med Hypotheses 73: 542-547.
40. Chytil A, Magnuson MA, Wright CV, Moses HL (2002) Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 32: 73-75.
41. DasGupta R, Fuchs E (1999) Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126: 4557-4568.
42. Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, et al. (1998) Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 78: 319-333.
43. Everhart MB, Han W, Parman KS, Polosukhin VV, Zeng H, et al. (2005) Intratracheal administration of liposomal clodronate accelerates alveolar macrophage reconstitution following fetal liver transplantation. J Leukoc Biol 77: 173-180.
44. Anumanthan G, Makari JH, Honea L, Thomas JC, Wills ML, et al. (2008) Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol 180: 1778-1783.
45. Spagnoli A, Longobardi L, O'Rear L (2005) Cartilage disorders: potential therapeutic use of mesenchymal stem cells. Endocr Dev 9: 17-30.
46. Alfaro MP, Pagni M, Vincent A, Atkinson J, Hill MF, et al. (2008) The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci U S A 105: 18366-18371.